|
|
|
|
|
|
Sponsors and Collaborators: |
University of Edinburgh Umeå University |
Information provided by: | University of Edinburgh |
ClinicalTrials.gov Identifier: | NCT00745693 |
The purpose of this study is to identify the role of endothelin 1 (a natural vasoconstrictor) in the adverse vascular effects demonstrated after exposure to air pollution
Condition | Intervention |
Coronary Disease |
Drug: Endothelin-1 Drug: BQ-123 and BQ-788 |
MedlinePlus related topics: | Air Pollution |
Drug Information available for: | BQ 123 |
Study Type: | Interventional |
Study Design: | Basic Science, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Crossover Assignment |
Official Title: | The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin |
Enrollment: | 15 |
Study Start Date: | March 2008 |
Study Completion Date: | May 2008 |
Primary Completion Date: | May 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
1: Experimental
1 hour exposure to filtered air, followed by forearm venous occlusion plethysmography at 2 hours after the exposure and infusion of endothelin-1 (5pmol/min)
|
Drug: Endothelin-1
Intra-arterial infusion of Endothelin-1 at 5pmol/min for 1 hour during venous occlusion plethysmography
|
2: Experimental
1 hour exposure to filtered air, followed by forearm venous occlusion plethysmography at 2 hours after the exposure and infusion of endothelin receptor antagonists BQ-123 and BQ-788
|
Drug: BQ-123 and BQ-788
1 hour intra-arterial infusion of BQ-123 at 10nmol/min followed by co-infusion of BQ-788 at 1nmol/min for a further hour during forearm venous occlusion plethysmography
|
3: Experimental
1 hour exposure to dilute diesel exhaust (300mcg/m3), followed by forearm venous occlusion plethysmography at 2 hours after the exposure and infusion of endothelin-1 (5pmol/min)
|
Drug: Endothelin-1
Intra-arterial infusion of Endothelin-1 at 5pmol/min for 1 hour during venous occlusion plethysmography
|
4: Experimental
1 hour exposure to dilute diesel exhaust (300mcg/m3), followed by forearm venous occlusion plethysmography at 2 hours after the exposure and infusion of endothelin receptor antagonists BQ-123 and BQ-788
|
Drug: BQ-123 and BQ-788
1 hour intra-arterial infusion of BQ-123 at 10nmol/min followed by co-infusion of BQ-788 at 1nmol/min for a further hour during forearm venous occlusion plethysmography
|
Air pollution is a major problem, and can be linked to around 5% of all deaths worldwide each year. There are strong associations between air pollution exposure and heart disease but we do not yet understand how these harmful effects are mediated. Understanding this mechanism is likely to have a major impact on the way we treat patients with heart disease and have the potential to shape future environmental health policy. The upregulation of Endothelin-1 provides a plausible mechanism for these harmful effects, and we plan to investigate this in more depth in the human forearm following exposure to diesel exhaust.
Ages Eligible for Study: | 18 Years to 35 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Sweden, Västerbottens | |||||
Umeå University | |||||
Umeå, Västerbottens, Sweden, SE-901 87 |
University of Edinburgh |
Umeå University |
Principal Investigator: | Jeremy P Langrish, MB BCh MRCP | University of Edinburgh |
Study Director: | Anders Blomberg, MD | Umeå University |
Study Director: | Thomas Sandström, MD | Umeå University |
Study Director: | David E Newby, MD FRCP | University of Edinburgh |
Responsible Party: | University of Edinburgh ( Dr Jeremy Langrish ) |
Study ID Numbers: | Res08/A116 |
First Received: | September 2, 2008 |
Last Updated: | September 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00745693 |
Health Authority: | Sweden: Regional Ethical Review Board |
|
|
|
|